Efficacy and Safety of KN057 Prophylaxis in Patients With Haemophilia A or B With Inhibitors

Conditions: Hemophilia A With Inhibitor; Hemophilia B With Inhibitor Interventions: Drug: KN057 Sponsors: Suzhou Alphamab Co., Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials